Development
Zimmer Biomet Holdings, Inc.
ZBH
$92.38
$0.460.50%
NYSE
| 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | |
|---|---|---|---|---|---|
| Net Income | 419.20M | 162.70M | 209.60M | 232.50M | -130.50M |
| Total Depreciation and Amortization | 241.20M | 241.20M | 237.50M | 231.80M | 228.50M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -70.60M | 15.80M | 34.10M | 22.80M | 254.80M |
| Change in Net Operating Assets | -1.40M | -82.10M | -133.30M | -179.40M | -108.60M |
| Cash from Operations | 588.40M | 337.60M | 347.90M | 307.70M | 244.20M |
| Capital Expenditure | -141.70M | -148.80M | -182.80M | -129.50M | -129.50M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -102.00M | 0.00 | -14.00M | -18.90M | 0.00 |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 23.00M | -16.90M | -46.30M | -1.00M | 17.00M |
| Cash from Investing | -220.70M | -165.70M | -243.10M | -149.40M | -112.50M |
| Total Debt Issued | 499.80M | -570.00M | 200.00M | 370.00M | 375.00M |
| Total Debt Repaid | -305.00M | 405.00M | -265.00M | -280.20M | -525.80M |
| Issuance of Common Stock | 19.30M | 20.70M | 25.10M | 36.00M | 14.90M |
| Repurchase of Common Stock | -410.30M | 0.00 | -14.30M | -267.60M | -126.40M |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -50.20M | -50.10M | -50.30M | -50.30M | -50.40M |
| Other Financing Activities | -5.00M | -1.60M | -4.90M | -14.60M | -700.00K |
| Cash from Financing | -251.40M | -196.00M | -109.40M | -206.70M | -313.40M |
| Foreign Exchange rate Adjustments | 7.40M | -3.60M | -5.80M | 2.90M | 12.00M |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 123.70M | -27.70M | -10.40M | -45.50M | -169.70M |